TickerLeague.com
AbbVie Inc. logo

AbbVie

ABBV

Healthcare
NYSE
US
CIK:0001551152

About AbbVie

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque p…

Power Profile

Revenue Counter

AbbVie earns $1.94K/sec (TTM: $61.16B)

Revenue counter

Earnings Counter

AbbVie earns $134.01/sec net profit (TTM: $4.23B)

Earnings counter

Economic Scale

AbbVie revenue exceeds Bolivia GDP ($54.9B)

Economic scale

What If Invested

See what $1,000 invested in AbbVie would be worth today

What if invested

How it makes money

Visual revenue breakdown: how AbbVie generates income and where it flows

How it makes money

Seasonality

Monthly and quarterly returns heatmap, seasonality matrix for AbbVie

View seasonality
Q1 2026
Report Date
May 1, 2026
BMO
Lock in
44 days 4 hours
Revenue
Analyst Forecast
$14.72B
EPS
Analyst Forecast
3.01
Q4 2025
Report Date
Feb 4, 2026
BMO
Lock in
Locked
Revenue
Actual
$16.62B
Analyst Forecast
$16.41B
EPS
Actual
2.71
Analyst Forecast
3.02